Literature DB >> 6115926

A pre-junctional action of 5-hydroxytryptamine and methysergide on noradrenergic nerves in dog isolated saphenous vein.

A D Watts, W Feniuk, P P Humphrey.   

Abstract

Electrical stimulation (2 Hz for 2 min) of dog isolated saphenous vein strips pre-incubated with tritiated noradrenaline increased the overflow of tritium of which about 80% was noradrenaline. 5-Hydroxytryptamine (5-HT; 1.0 x 10-9-1.0 x 10-7 mol litre-1) and methysergide (3.0 x 10-8-3.0 x 10-6 mol litre-1) inhibited the induced overflow of total tritium by a maximum of 78 +/- 4% and 47 +/- 7% respectively (mean +/- s.e. mean, n=6 for each). Methysergide was about 30 times less potent than 5-HT and the maximum inhibition obtained was less than with 5-HT. Both compounds inhibited electrically-induced contractions and overflow of tritiated noradrenaline. Their inhibitory actions on tritium overflow were little affected by phentolamine (1.0 x 10-6 mol litre-1) or cyproheptadine (1.0 x 10-6 mol litre-1), nor was the inhibitory effect of methysergide on electrically induced contractions antagonized by atropine, mepyramine, cimetidine or propranolol. The findings suggest that the prejunctional inhibitory effect of methysergide may be mediated via stimulation of a 5-HT receptor which, unlike the D-receptor, is not blocked by cyproheptadine. The possibility that the pre-junctional 5-HT receptor in the dog saphenous vein is the same as the post-junctional receptor in this preparation is discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6115926     DOI: 10.1111/j.2042-7158.1981.tb13850.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  11 in total

1.  An inhibitory prejunctional 5-HT1-like receptor in the isolated perfused rat kidney. Apparent distinction from the 5-HT1A, 5-HT1B and 5-HT1C subtypes.

Authors:  K G Charlton; R A Bond; D E Clarke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-01       Impact factor: 3.000

2.  The selective carotid arterial vasoconstrictor action of GR43175 in anaesthetized dogs.

Authors:  W Feniuk; P P Humphrey; M J Perren
Journal:  Br J Pharmacol       Date:  1989-01       Impact factor: 8.739

3.  Presynaptic alpha-adrenoceptors: do exogenous and neuronally released noradrenaline act at different sites?

Authors:  D J Baker; G M Drew; A Hilditch
Journal:  Br J Pharmacol       Date:  1984-03       Impact factor: 8.739

4.  Inhibition of noradrenaline release via presynaptic 5-HT1B receptors of the rat vena cava.

Authors:  G J Molderings; K Fink; E Schlicker; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-09       Impact factor: 3.000

5.  Evidence for common pharmacological properties of [3H]5-hydroxytryptamine binding sites, presynaptic 5-hydroxytryptamine autoreceptors in CNS and inhibitory presynaptic 5-hydroxytryptamine receptors on sympathetic nerves.

Authors:  G Engel; M Göthert; E Müller-Schweinitzer; E Schlicker; L Sistonen; P A Stadler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-09       Impact factor: 3.000

6.  Characterization of presynaptic 5-HT receptors on adrenergic nerves supplying the bovine ovarian follicle.

Authors:  P Kannisto; C Owman; G Schmidt; N O Sjöberg
Journal:  Br J Pharmacol       Date:  1987-11       Impact factor: 8.739

7.  [Pilot studies with a serotonin agonist (AH 25086 B). Efficacy and tolerance in acute migraine attacks.].

Authors:  A Doenicke; E Siegel
Journal:  Schmerz       Date:  1987-07       Impact factor: 1.107

8.  Receptor-mediated effects of serotonin and 5-methoxytryptamine on noradrenaline release in the rat vena cava and in the heart of the pithed rat.

Authors:  M Göthert; E Schlicker; P Kollecker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-02       Impact factor: 3.000

9.  GR43175, a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein.

Authors:  P P Humphrey; W Feniuk; M J Perren; H E Connor; A W Oxford; L H Coates; D Butina
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

10.  The actions of 5-hydroxytryptamine receptor agonists and antagonists at pre- and postjunctional level on the canine saphenous vein.

Authors:  M Q Paiva; M M Caramona; W Osswald
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-12       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.